Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Zentralbl Gynakol ; 118(12): 689-92, 1996.
Article in German | MEDLINE | ID: mdl-9082709

ABSTRACT

Report about continuous fetal monitoring of heart rate and movements 9-30 hours after diazepam-intoxication. in an early stage after intoxication fetal movements are associated with FHF-decelerations, later on with accelerations. A sinusoidal like pattern may be caused by fetal suckling movements.


Subject(s)
Anti-Anxiety Agents/poisoning , Cardiotocography/drug effects , Diazepam/poisoning , Kinetocardiography/drug effects , Anti-Anxiety Agents/pharmacokinetics , Diazepam/pharmacokinetics , Dose-Response Relationship, Drug , Female , Fetal Movement/drug effects , Heart Rate, Fetal/drug effects , Humans , Infant, Newborn , Pregnancy , Pregnancy Trimester, Third
2.
Acta Cardiol ; 46(5): 567-75, 1991.
Article in English | MEDLINE | ID: mdl-1789051

ABSTRACT

The inotropic effect of a per os single dose of 200 mg disopyramide phosphate was studied in 25 patients during the second week after acute myocardial infarction with no signs of heart failure. Systolic time intervals and the indices derived from the uncalibrated differentiated carotidogram and apexcardiogram were used to assess changes in cardiac performance. The results were as follows: a) Reduction by 3.2% of the haemodynamic ratio LVET/PEP. b) Reduction by 20.1% of the maximal relative upstroke velocity in the differentiated carotidogram (B/S2) p less than 0.05). c) Decrease by 13.1% of the ratio, total amplitude/dicrotic deflection (T/S2) in the same tracing (p less than 0.05). d) Decrease by 2.8% of the ratio, early systolic wave/early diastolic complex wave (b/ef) in the differentiated apexcardiogram. e) Increase by 3.2% of the ratio early diastolic complex total amplitude (ef/ZN) in the previous tracing. The above changes were indicative of a slight negative inotropic effect of the drug.


Subject(s)
Disopyramide/pharmacology , Myocardial Infarction/physiopathology , Administration, Oral , Adult , Aged , Blood Pressure/drug effects , Disopyramide/administration & dosage , Electrocardiography/drug effects , Heart Rate/drug effects , Hemodynamics/drug effects , Humans , Kinetocardiography/drug effects , Male , Middle Aged , Myocardial Infarction/complications , Time Factors , Ventricular Function, Left/drug effects
3.
Bratisl Lek Listy ; 91(9): 701-4, 1990 Sep.
Article in Czech | MEDLINE | ID: mdl-2224552

ABSTRACT

Mechanocardiographic investigations were carried out in a group of eight patients with hypertrophic obstructive cardiomyopathy (HOCM) who had been implanted a DDD pacemaker which allowed efficient therapy to be administered in the combination of metoprolol in the dose of 300 mg/day and verapamil in doses of 240-480 mg/day. The investigation was repeated one week after temporary withdrawal of verapamil. The control group consisted of six patients with idiopathic third-degree-complete AV block with implanted DDD pacemakers. Over the period of 24 hours before investigation, these patients received 300 mg of metoprolol. All the patients had the same heart rate (70 bpm) and a constant PQ interval (0.18 s). Statistical analysis of the obtained data revealed the following findings: 1. There was no difference between the control group and the group of HOCM patients treated with verapamil. 2. Withdrawal of verapamil in HOCM patients resulted in a significant prolongation of the 2-0 interval and shortening of the O-c interval recorded on apexcardiogram compared to the control group. In conclusion, verapamil affects LV diastolic parameters in patients with HOCM and the changes are compatible with the beneficial effects of verapamil. These changes may however result partly from increased left atrial pressure due to atrial poisoning with verapamil.


Subject(s)
Cardiomyopathy, Hypertrophic/physiopathology , Myocardial Contraction , Verapamil/therapeutic use , Cardiomyopathy, Hypertrophic/drug therapy , Cardiomyopathy, Hypertrophic/therapy , Diastole/drug effects , Electrocardiography/drug effects , Humans , Kinetocardiography/drug effects , Myocardial Contraction/drug effects , Pacemaker, Artificial , Systole/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...